Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06809218 · ClinicalTrials.gov registry record · Phase 3
A Pooled Analysis of Long-Term Outcomes After Inhaled Isoflurane Via the Sedaconda ACD-S Compared to Intravenous Propofol
A Phase 3 study of Sedation and Post-Intensive Care Syndrome, sponsored by Sedana Medical.
- Active
- Registry status
- Phase 3
- Development phase
- 312
- Enrollment target
- 1
- Study location
NCT06809218 is a Phase 3 study of Sedation and Post-Intensive Care Syndrome that is active but no longer recruiting, run by Sedana Medical. The registered enrollment target is 312 participants, below the 100,160-participant average among 12 other Sedation trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06809218, a Phase 3 study of Sedation and Post-Intensive Care Syndrome, is active but no longer recruiting, sponsored by Sedana Medical.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 3
- Development phase
- 312 participants
- Enrollment target
- 1
- Study location
Study Summary
This pooled analysis will assess Cognitive, Mental Health, Functioning, and Quality of Life Assessments data from the Phase 3 registration studies INSPiRE-ICU 1 (NCT05312385) and INSPiRE-ICU 2 (NCT05327296) to explore potential differences in Long-Term Outcomes at 3 and 6 months after treatment between critically ill mechanically ventilated patients sedated with inhaled isoflurane compared to sedated with intravenous propofol. The analyses were pre-planned and agreed prior to completion of enrollment of either study.
Conditions Studied
Interventions
- DRUG Inhaled isoflurane administered by Sedaconda ACD-S
- DRUG Intravenous infusion of propofol
Study Locations (1)
Tennessee
- The Critical Illness, Brain Dysfunction and Survivorship (CIBS) Center - Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 312 participants |
| Start Date | 2022-04-22 |
| Est. Completion | 2025-01-30 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06809218
The ClinicalTrials.gov registry entry for NCT06809218 describes a study currently listed as active not recruiting, categorized as Phase 3. The registered enrollment target is 312 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 100,160-participant average among 12 other Sedation trials with a reported enrollment target (100% lower). The listed sponsor is Sedana Medical, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Sedation appearing as the primary indexed condition, and to 2 interventions - of which Inhaled isoflurane administered by Sedaconda ACD-S is the first listed.
NCT06809218 reports 1 study location spanning 1 distinct geographic area - top geographies include Tennessee.
Frequently Asked Questions
What is clinical trial NCT06809218 about?
NCT06809218 is a clinical study titled "A Pooled Analysis of Long-Term Outcomes After Inhaled Isoflurane Via the Sedaconda ACD-S Compared to Intravenous Propofol". This pooled analysis will assess Cognitive, Mental Health, Functioning, and Quality of Life Assessments data from the Phase 3 registration studies INSPiRE-ICU 1 (NCT05312385) and INSPiRE-ICU 2 (NCT05327296) to explore potential differences in Long-Term Outcomes at 3 and 6 months after treatment betw...
What is the current status of trial NCT06809218?
This trial is currently active not recruiting. It is a Phase 3 study. The enrollment target is 312 participants. The study started on 2022-04-22. Estimated completion is 2025-01-30.
What conditions does trial NCT06809218 study?
This clinical trial studies the following conditions: Sedation, Post-Intensive Care Syndrome.
What interventions are being tested in trial NCT06809218?
The interventions under investigation include: Inhaled isoflurane administered by Sedaconda ACD-S (DRUG), Intravenous infusion of propofol (DRUG).
Who is sponsoring clinical trial NCT06809218?
This trial is sponsored by Sedana Medical, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06809218 being conducted?
This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sedation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Sedation During Endoscopy Using Remimazolam: Efficacy in a Novel Exploration
RECRUITING · Phase 3
-
Efficacy and Safety of Inhaled Isoflurane Delivered Via the Sedaconda ACD-S Compared to Intravenous Propofol for Sedation of Mechanically Ventilated Intensive Care Unit Adult Patients (INSPiRE-ICU1)
ACTIVE NOT RECRUITING · Phase 3
-
Efficacy and Safety of Inhaled Isoflurane Delivered Via the Sedaconda ACD-S Compared to Intravenous Propofol for Sedation of Mechanically Ventilated Intensive Care Unit Adult Patients (INSPiRE-ICU2)
COMPLETED · Phase 3
-
Oral vs IV Sedation for Cataract Surgery in Older Adults
RECRUITING · Phase 4
-
Neurosteer Bedside Monitoring System
RECRUITING · NA
-
The Million Anesthesia Cases Study (MACS) - a Cohort Study of Preoperative Fasting and Perioperative Outcomes
RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.